SCHEMBL22454076

SCHEMBL22454076

Cc1ncc(B2CC(C)(C)C(C)(C)C2)cc1F

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.30
VRK1 Q99986 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12254192 0.81
SCHEMBL2427096 0.72 LPL (0.42)
SCHEMBL24092899 0.71 HCAR2 (0.36)
SCHEMBL530791 0.71 VRK1 (0.30) VRK1
SCHEMBL22553377 0.69 ADRA2A (0.32)
SCHEMBL21892356 0.66
SCHEMBL20888424 0.65
SCHEMBL24092919 0.64 ALDH1A1 (0.31)
SCHEMBL22551967 0.64 NOS3 (0.41)
SCHEMBL4137228 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190754-A1 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. (US) 2020-09-24 WO disclosed